What is the current valuation of the Hereditary Cancer Testing Market?

As of 2024, the Hereditary Cancer Testing Market was valued at approximately 8.961 USD Billion. Read More

What is the projected market size for the Hereditary Cancer Testing Market by 2035?

The market is expected to reach a valuation of 25.19 USD Billion by 2035. Read More

What is the expected CAGR for the Hereditary Cancer Testing Market during the forecast period?

The market is projected to grow at a CAGR of 9.85% from 2025 to 2035. Read More

Which companies are considered key players in the Hereditary Cancer Testing Market?

Key players include Myriad Genetics, Invitae, Ambry Genetics, GeneDx, Fulgent Genetics, Color Genomics, 23andMe, PathAI, and Natera. Read More

What are the main segments of the Hereditary Cancer Testing Market?

The main segments include Test Type, Technology, Sample Type, End User, and Application. Read More

How does the Genetic Testing segment perform in terms of market valuation?

The Genetic Testing segment is projected to grow from 3.5 USD Billion in 2024 to 10.5 USD Billion by 2035. Read More

What is the expected growth for Next-Generation Sequencing (NGS) technology?

Next-Generation Sequencing (NGS) is anticipated to increase from 4.478 USD Billion in 2024 to 12.5 USD Billion by 2035. Read More

Which sample type is expected to dominate the market by 2035?

Blood samples are likely to dominate, growing from 3.584 USD Billion in 2024 to 10.25 USD Billion by 2035. Read More

What is the projected market size for hospitals as end users in 2035?

Hospitals are expected to grow from 3.584 USD Billion in 2024 to 10.45 USD Billion by 2035. Read More

What applications are driving growth in the Hereditary Cancer Testing Market?

Applications such as Hereditary Cancer Risk Assessment and Carrier Status Identification are projected to grow significantly, each reaching 7.56 USD Billion by 2035. Read More

Hereditary Cancer Testing Market

Hereditary Cancer Testing Market Research Report By Test Type (Genetic Testing, Carrier Screening, Expanded Panel Testing, Single Gene Testing), By Technology (PCR (Polymerase Chain Reaction), Next-Generation Sequencing (NGS), Sanger Sequencing), By Sample Type (Blood Sample, Saliva Sample, Tissue Sample), By End User (Hospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings), By Application (Hereditary Cancer Risk Assessment, Carrier Status Identification, Prenatal Testing, Predictive Testing) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

9.85%

2024 Market Size

$ 8.96 Billion

2035 Market Size

$ 25.19 Billion

Healthcare ● Updated April 2026 Report ID: MRFR/HC/30538-HCR | Pages: 100 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Test Type (USD Billion) | |
  1. 4.1.1 Genetic Testing | |
  2. 4.1.2 Carrier Screening | |
  3. 4.1.3 Expanded Panel Testing | |
  4. 4.1.4 Single Gene Testing |
2. 4.2 Healthcare, BY Technology (USD Billion) | |
  1. 4.2.1 PCR (Polymerase Chain Reaction) | |
  2. 4.2.2 Next-Generation Sequencing (NGS) | |
  3. 4.2.3 Sanger Sequencing |
3. 4.3 Healthcare, BY Sample Type (USD Billion) | |
  1. 4.3.1 Blood Sample | |
  2. 4.3.2 Saliva Sample | |
  3. 4.3.3 Tissue Sample |
4. 4.4 Healthcare, BY End User (USD Billion) | |
  1. 4.4.1 Hospitals | |
  2. 4.4.2 Diagnostic Laboratories | |
  3. 4.4.3 Research Institutes | |
  4. 4.4.4 Home Care Settings |
5. 4.5 Healthcare, BY Application (USD Billion) | |
  1. 4.5.1 Hereditary Cancer Risk Assessment | |
  2. 4.5.2 Carrier Status Identification | |
  3. 4.5.3 Prenatal Testing | |
  4. 4.5.4 Predictive Testing |
6. 4.6 Healthcare, BY Region (USD Billion) | |
  1. 4.6.1 North America | | |
    1. 4.6.1.1 US | | |
    2. 4.6.1.2 Canada | |
  2. 4.6.2 Europe | | |
    1. 4.6.2.1 Germany | | |
    2. 4.6.2.2 UK | | |
    3. 4.6.2.3 France | | |
    4. 4.6.2.4 Russia | | |
    5. 4.6.2.5 Italy | | |
    6. 4.6.2.6 Spain | | |
    7. 4.6.2.7 Rest of Europe | |
  3. 4.6.3 APAC | | |
    1. 4.6.3.1 China | | |
    2. 4.6.3.2 India | | |
    3. 4.6.3.3 Japan | | |
    4. 4.6.3.4 South Korea | | |
    5. 4.6.3.5 Malaysia | | |
    6. 4.6.3.6 Thailand | | |
    7. 4.6.3.7 Indonesia | | |
    8. 4.6.3.8 Rest of APAC | |
  4. 4.6.4 South America | | |
    1. 4.6.4.1 Brazil | | |
    2. 4.6.4.2 Mexico | | |
    3. 4.6.4.3 Argentina | | |
    4. 4.6.4.4 Rest of South America | |
  5. 4.6.5 MEA | | |
    1. 4.6.5.1 GCC Countries | | |
    2. 4.6.5.2 South Africa | | |
    3. 4.6.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Myriad Genetics (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Invitae (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Ambry Genetics (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 GeneDx (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Fulgent Genetics (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Color Genomics (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 23andMe (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 PathAI (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Natera (US) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY TEST TYPE |
7. 6.4 US MARKET ANALYSIS BY TECHNOLOGY |
8. 6.5 US MARKET ANALYSIS BY SAMPLE TYPE |
9. 6.6 US MARKET ANALYSIS BY END USER |
10. 6.7 US MARKET ANALYSIS BY APPLICATION |
11. 6.8 CANADA MARKET ANALYSIS BY TEST TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY TECHNOLOGY |
13. 6.10 CANADA MARKET ANALYSIS BY SAMPLE TYPE |
14. 6.11 CANADA MARKET ANALYSIS BY END USER |
15. 6.12 CANADA MARKET ANALYSIS BY APPLICATION |
16. 6.13 EUROPE MARKET ANALYSIS |
17. 6.14 GERMANY MARKET ANALYSIS BY TEST TYPE |
18. 6.15 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
19. 6.16 GERMANY MARKET ANALYSIS BY SAMPLE TYPE |
20. 6.17 GERMANY MARKET ANALYSIS BY END USER |
21. 6.18 GERMANY MARKET ANALYSIS BY APPLICATION |
22. 6.19 UK MARKET ANALYSIS BY TEST TYPE |
23. 6.20 UK MARKET ANALYSIS BY TECHNOLOGY |
24. 6.21 UK MARKET ANALYSIS BY SAMPLE TYPE |
25. 6.22 UK MARKET ANALYSIS BY END USER |
26. 6.23 UK MARKET ANALYSIS BY APPLICATION |
27. 6.24 FRANCE MARKET ANALYSIS BY TEST TYPE |
28. 6.25 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
29. 6.26 FRANCE MARKET ANALYSIS BY SAMPLE TYPE |
30. 6.27 FRANCE MARKET ANALYSIS BY END USER |
31. 6.28 FRANCE MARKET ANALYSIS BY APPLICATION |
32. 6.29 RUSSIA MARKET ANALYSIS BY TEST TYPE |
33. 6.30 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
34. 6.31 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE |
35. 6.32 RUSSIA MARKET ANALYSIS BY END USER |
36. 6.33 RUSSIA MARKET ANALYSIS BY APPLICATION |
37. 6.34 ITALY MARKET ANALYSIS BY TEST TYPE |
38. 6.35 ITALY MARKET ANALYSIS BY TECHNOLOGY |
39. 6.36 ITALY MARKET ANALYSIS BY SAMPLE TYPE |
40. 6.37 ITALY MARKET ANALYSIS BY END USER |
41. 6.38 ITALY MARKET ANALYSIS BY APPLICATION |
42. 6.39 SPAIN MARKET ANALYSIS BY TEST TYPE |
43. 6.40 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
44. 6.41 SPAIN MARKET ANALYSIS BY SAMPLE TYPE |
45. 6.42 SPAIN MARKET ANALYSIS BY END USER |
46. 6.43 SPAIN MARKET ANALYSIS BY APPLICATION |
47. 6.44 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE |
48. 6.45 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
49. 6.46 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE |
50. 6.47 REST OF EUROPE MARKET ANALYSIS BY END USER |
51. 6.48 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
52. 6.49 APAC MARKET ANALYSIS |
53. 6.50 CHINA MARKET ANALYSIS BY TEST TYPE |
54. 6.51 CHINA MARKET ANALYSIS BY TECHNOLOGY |
55. 6.52 CHINA MARKET ANALYSIS BY SAMPLE TYPE |
56. 6.53 CHINA MARKET ANALYSIS BY END USER |
57. 6.54 CHINA MARKET ANALYSIS BY APPLICATION |
58. 6.55 INDIA MARKET ANALYSIS BY TEST TYPE |
59. 6.56 INDIA MARKET ANALYSIS BY TECHNOLOGY |
60. 6.57 INDIA MARKET ANALYSIS BY SAMPLE TYPE |
61. 6.58 INDIA MARKET ANALYSIS BY END USER |
62. 6.59 INDIA MARKET ANALYSIS BY APPLICATION |
63. 6.60 JAPAN MARKET ANALYSIS BY TEST TYPE |
64. 6.61 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
65. 6.62 JAPAN MARKET ANALYSIS BY SAMPLE TYPE |
66. 6.63 JAPAN MARKET ANALYSIS BY END USER |
67. 6.64 JAPAN MARKET ANALYSIS BY APPLICATION |
68. 6.65 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE |
69. 6.66 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
70. 6.67 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE |
71. 6.68 SOUTH KOREA MARKET ANALYSIS BY END USER |
72. 6.69 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
73. 6.70 MALAYSIA MARKET ANALYSIS BY TEST TYPE |
74. 6.71 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
75. 6.72 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE |
76. 6.73 MALAYSIA MARKET ANALYSIS BY END USER |
77. 6.74 MALAYSIA MARKET ANALYSIS BY APPLICATION |
78. 6.75 THAILAND MARKET ANALYSIS BY TEST TYPE |
79. 6.76 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
80. 6.77 THAILAND MARKET ANALYSIS BY SAMPLE TYPE |
81. 6.78 THAILAND MARKET ANALYSIS BY END USER |
82. 6.79 THAILAND MARKET ANALYSIS BY APPLICATION |
83. 6.80 INDONESIA MARKET ANALYSIS BY TEST TYPE |
84. 6.81 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
85. 6.82 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE |
86. 6.83 INDONESIA MARKET ANALYSIS BY END USER |
87. 6.84 INDONESIA MARKET ANALYSIS BY APPLICATION |
88. 6.85 REST OF APAC MARKET ANALYSIS BY TEST TYPE |
89. 6.86 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
90. 6.87 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE |
91. 6.88 REST OF APAC MARKET ANALYSIS BY END USER |
92. 6.89 REST OF APAC MARKET ANALYSIS BY APPLICATION |
93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
94. 6.91 BRAZIL MARKET ANALYSIS BY TEST TYPE |
95. 6.92 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
96. 6.93 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE |
97. 6.94 BRAZIL MARKET ANALYSIS BY END USER |
98. 6.95 BRAZIL MARKET ANALYSIS BY APPLICATION |
99. 6.96 MEXICO MARKET ANALYSIS BY TEST TYPE |
100. 6.97 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
101. 6.98 MEXICO MARKET ANALYSIS BY SAMPLE TYPE |
102. 6.99 MEXICO MARKET ANALYSIS BY END USER |
103. 6.100 MEXICO MARKET ANALYSIS BY APPLICATION |
104. 6.101 ARGENTINA MARKET ANALYSIS BY TEST TYPE |
105. 6.102 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
106. 6.103 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE |
107. 6.104 ARGENTINA MARKET ANALYSIS BY END USER |
108. 6.105 ARGENTINA MARKET ANALYSIS BY APPLICATION |
109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE |
110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE |
112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
114. 6.111 MEA MARKET ANALYSIS |
115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE |
116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE |
118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY END USER |
119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE |
121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE |
123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY END USER |
124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
125. 6.122 REST OF MEA MARKET ANALYSIS BY TEST TYPE |
126. 6.123 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
127. 6.124 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE |
128. 6.125 REST OF MEA MARKET ANALYSIS BY END USER |
129. 6.126 REST OF MEA MARKET ANALYSIS BY APPLICATION |
130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
131. 6.128 RESEARCH PROCESS OF MRFR |
132. 6.129 DRO ANALYSIS OF HEALTHCARE |
133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
136. 6.133 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE) |
137. 6.134 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion) |
138. 6.135 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
139. 6.136 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
140. 6.137 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE) |
141. 6.138 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion) |
142. 6.139 HEALTHCARE, BY END USER, 2024 (% SHARE) |
143. 6.140 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
144. 6.141 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
145. 6.142 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
147. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.2.5 BY APPLICATION, 2025-2035 (USD Billion) |
149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.3.5 BY APPLICATION, 2025-2035 (USD Billion) |
150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.4.5 BY APPLICATION, 2025-2035 (USD Billion) |
151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.5.5 BY APPLICATION, 2025-2035 (USD Billion) |
152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.6.5 BY APPLICATION, 2025-2035 (USD Billion) |
153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.7.5 BY APPLICATION, 2025-2035 (USD Billion) |
154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.8.5 BY APPLICATION, 2025-2035 (USD Billion) |
155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.9.5 BY APPLICATION, 2025-2035 (USD Billion) |
156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.10.5 BY APPLICATION, 2025-2035 (USD Billion) |
157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.11.5 BY APPLICATION, 2025-2035 (USD Billion) |
158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.12.5 BY APPLICATION, 2025-2035 (USD Billion) |
159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.13.5 BY APPLICATION, 2025-2035 (USD Billion) |
160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.14.5 BY APPLICATION, 2025-2035 (USD Billion) |
161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.15.5 BY APPLICATION, 2025-2035 (USD Billion) |
162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.16.5 BY APPLICATION, 2025-2035 (USD Billion) |
163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.17.5 BY APPLICATION, 2025-2035 (USD Billion) |
164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.18.5 BY APPLICATION, 2025-2035 (USD Billion) |
165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.19.5 BY APPLICATION, 2025-2035 (USD Billion) |
166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.20.5 BY APPLICATION, 2025-2035 (USD Billion) |
167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.21.5 BY APPLICATION, 2025-2035 (USD Billion) |
168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.22.5 BY APPLICATION, 2025-2035 (USD Billion) |
169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.23.5 BY APPLICATION, 2025-2035 (USD Billion) |
170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.24.5 BY APPLICATION, 2025-2035 (USD Billion) |
171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.25.5 BY APPLICATION, 2025-2035 (USD Billion) |
172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.26.5 BY APPLICATION, 2025-2035 (USD Billion) |
173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.27.5 BY APPLICATION, 2025-2035 (USD Billion) |
174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.28.5 BY APPLICATION, 2025-2035 (USD Billion) |
175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.29.5 BY APPLICATION, 2025-2035 (USD Billion) |
176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY END USER, 2025-2035 (USD Billion) | |
  5. 7.30.5 BY APPLICATION, 2025-2035 (USD Billion) |
177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
178. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Hereditary Cancer Testing Market Segmentation

Hereditary Cancer Testing Market By Test Type (USD Billion, 2025-2035)

Genetic Testing
Carrier Screening
Expanded Panel Testing
Single Gene Testing

Hereditary Cancer Testing Market By Hereditary Cancer Testing Market (USD Billion, 2025-2035)

PCR (Polymerase Chain Reaction)
Next-Generation Sequencing (NGS)
Sanger Sequencing

Hereditary Cancer Testing Market By Sample Type (USD Billion, 2025-2035)

Blood Sample
Saliva Sample
Tissue Sample

Hereditary Cancer Testing Market By End User (USD Billion, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutes
Home Care Settings

Hereditary Cancer Testing Market By Application (USD Billion, 2025-2035)

Hereditary Cancer Risk Assessment
Carrier Status Identification
Prenatal Testing
Predictive Testing

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”